File Download
  Patent History
  • Application
    CN 20048029686 2004-08-13
  • Publication
    CN 100549172 2009-10-14
Supplementary

published patent: Compositions and methods for prognosis and therapy of liver cancer

TitleCompositions and methods for prognosis and therapy of liver cancer
Priority Date2003-08-13 US 10/494981P
Inventors
Issue Date2009
Citation
China Published Patent Application CN 100549172. Beijing, PRC: State Intellectual Property Office (SIPO) of the P.R.C., 2009 How to Cite?
AbstractThis invention provides a composition comprising the following polynucleotide probes: IL7R (AA485865), NDRG1 (AA486403), EST1 (H50345), TRPC1 (AA017132), GFRA1 (AA512935), EST2 (AA454543), CLDNIO (R54559), DNALII (R93087), RBP5 (AA453198), EST3 (AA621761) , EST4 (N63706), PCOLCE (AA670200), TD02 (T72398) , EST5 (T47454), HISTlH2BD (N33927), PXMP2 (N70714), ACAS2 (AA455146), ANAPC7 (T68445), EST6 (AA576580), RBP5 (N92148), ANXAl (H63077), CKB (AA894557), ITGBLl (N52533), KPNA2 (AA676460), EST7 (W90740) and MEG3 (W85841) This invention further provides methods for determining the likelihood of recurrence of hepatocellular carcinoma (HCC) in a subject afflicted with HCC, for determining the likelihood of death of a subject afflicted with HCC or for determining whether to administer adjuvant therapy.
Persistent Identifierhttp://hdl.handle.net/10722/176603

 

DC FieldValueLanguage
dc.date.accessioned2012-11-30T08:38:13Z-
dc.date.available2012-11-30T08:38:13Z-
dc.date.issued2009-
dc.identifier.citationChina Published Patent Application CN 100549172. Beijing, PRC: State Intellectual Property Office (SIPO) of the P.R.C., 2009en_HK
dc.identifier.urihttp://hdl.handle.net/10722/176603-
dc.description.abstractThis invention provides a composition comprising the following polynucleotide probes: IL7R (AA485865), NDRG1 (AA486403), EST1 (H50345), TRPC1 (AA017132), GFRA1 (AA512935), EST2 (AA454543), CLDNIO (R54559), DNALII (R93087), RBP5 (AA453198), EST3 (AA621761) , EST4 (N63706), PCOLCE (AA670200), TD02 (T72398) , EST5 (T47454), HISTlH2BD (N33927), PXMP2 (N70714), ACAS2 (AA455146), ANAPC7 (T68445), EST6 (AA576580), RBP5 (N92148), ANXAl (H63077), CKB (AA894557), ITGBLl (N52533), KPNA2 (AA676460), EST7 (W90740) and MEG3 (W85841) This invention further provides methods for determining the likelihood of recurrence of hepatocellular carcinoma (HCC) in a subject afflicted with HCC, for determining the likelihood of death of a subject afflicted with HCC or for determining whether to administer adjuvant therapy.en_HK
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License For Public Patent Documentsen_US
dc.titleCompositions and methods for prognosis and therapy of liver canceren_HK
dc.typePatenten_US
dc.description.naturepublished_or_final_versionen_US
dc.contributor.inventorCheung, STen_HK
dc.contributor.inventorFan, STen_HK
patents.identifier.applicationCN 20048029686en_HK
patents.identifier.applicationZL200480029686.1-
patents.description.assigneeUNIV HONG KONG [HK]en_HK
patents.description.countryChina, PRCen_HK
patents.date.publication2009-10-14en_HK
patents.identifier.hkutechidSurg-2003-00126-3-
patents.date.application2004-08-13en_HK
patents.date.priority2003-08-13 US 10/494981Pen_HK
patents.description.ccCNen_HK
patents.identifier.publicationCN 100549172en_HK
patents.relation.familyCN 1867671 (A) 2006-11-22en_HK
patents.relation.familyCN 100549172 (C) 2009-10-14en_HK
patents.relation.familyHK 1098783 (A1) 2010-07-02en_HK
patents.relation.familyUS 2009325160 (A1) 2009-12-31en_HK
patents.relation.familyUS 8076077 (B2) 2011-12-13en_HK
patents.relation.familyUS 2005089895 (A1) 2005-04-28en_HK
patents.relation.familyWO 2005017150 (A1) 2005-02-24en_HK
patents.description.kindCen_HK
patents.typePatent_publisheden_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats